Related Experiment Video
Updated: May 31, 2026

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
Published on: March 21, 2021
Biomarkers in acute lung injury--marking forward progress
Nicolas Barnett1, Lorraine B Ware
1Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University, Nashville, TN 37232-2650, USA.
This review explores biomarkers for acute lung injury (ALI) prediction, diagnosis, and prognosis. It covers existing and emerging protein biomarkers, genomics, proteomics, and combined approaches for improved clinical indices.
Area of Science:
- Pulmonology
- Biomarker Discovery
- Critical Care Medicine
Background:
- Acute lung injury (ALI) presents significant diagnostic and prognostic challenges.
- Effective biomarkers are crucial for improving patient outcomes in ALI.
- Current research focuses on identifying reliable indicators for ALI management.
Purpose of the Study:
- To review the current state of biomarkers for acute lung injury (ALI).
- To define biomarkers and the objectives of biomarker research in ALI.
- To examine progress in protein, genomic, and proteomic biomarker identification and application.
Main Methods:
- Review of existing literature on protein biomarkers for ALI.
- Description of novel biomarkers with validation potential.
- Analysis of advancements in genomics and proteomics for biomarker discovery.
- Examination of combined clinical and molecular biomarker approaches.
Main Results:
- Comprehensive overview of established protein biomarkers in ALI.
- Identification of promising new biomarkers requiring further validation.
- Progress in high-throughput omics technologies for biomarker identification.
- Demonstration of enhanced diagnostic and prognostic accuracy through combined biomarker strategies.
Conclusions:
- Biomarker research in ALI is advancing across multiple fronts.
- Combining clinical predictors with molecular biomarkers offers improved diagnostic and prognostic capabilities.
- Further validation and integration of these biomarkers are essential for clinical practice.
Related Concept Videos
Acute Respiratory Failure-IV
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Physical Assessment of the Respiratory Tract II: Inspection
Chest Configuration
The chest configuration can...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-III
